×

Biotech's path to discovery: BioMarin CEO

8:33 AM ET Mon, 23 March 2015

Jean-Jacques Bienaime, BioMarin Pharmaceuticals CEO, discusses his company's bull run and new drugs to treat rare diseases, including Duchenne muscular dystrophy.